Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.
ClinicalTrials.gov ID
NCT00180024
Lead Sponsor
Technische Universität DresdenOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Last Update Posted
Sep 16, 2005Estimated
Start Date
Jan 2002
Completion Date
Sep 2005
Brief Summary
The hypothesis is tested that stimulation with angiotensin II after blockade of the AT1-receptor results in venodilation in human healthy subjects in vivo.
Healthy Subjects
irbesartan (drug)
Ages Eligible for Study
Adult (18-64)
Sexes Eligible for Study
Male
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
healthy subjects
Exclusion Criteria:
any relevant disease
Primary Purpose
Educational/Counseling/Training
Allocation
Non-Randomized
Interventional Model
Single Group Assignment
Masking
None (Open Label)
No central contacts
There are no central contacts for this study.
Institute of Clinical Pharmacology, Medical Faculty, University of Technology